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Short-chain fatty acid level and field cancerization
show opposing associations with enteroendocrine
cell number and neuropilin expression in patients
with colorectal adenoma
Danny CW Yu, Jonathan P Bury, James Tiernan, Jennifer S Waby, Carolyn A Staton, Bernard M Corfe*
Abstract
Background: Previous reports have suggested that the VEGF receptor neuropilin-1 (NRP-1) is expressed in a singly
dispersed subpopulation of cells in the normal colonic epithelium, but that expression becomes dysregulated
during colorectal carcinogenesis, with higher levels in tumour suggestive of a poor prognosis. We noted that the
spatial distribution and morphology if NRP-1 expressing cells resembles that of enteroendocrine cells (EEC) which
are altered in response to disease state including cancer and irritable bowel syndrome (IBS). We have shown that
NRP-1 is down-regulated by butyrate in colon cancer cell lines in vitro and we hypothesized that butyrate
produced in the lumen would have an analogous effect on the colon mucosa in vivo. Therefore we sought to
investigate whether NRP-1 is expressed in EEC and how NRP-1 and EEC respond to butyrate and other short-chain
fatty acids (SCFA - principally acetate and propionate). Additionally we sought to assess whether there is a field
effect around adenomas.
Methodology: Biopsies were collected at the mid-sigmoid, at the adenoma and at the contralateral wall (field) of 28
subjects during endoscopy. Samples were fixed for IHC and stained for either NRP-1 or for chromogranin A (CgA), a
marker of EEC. Stool sampling was undertaken to assess individuals’ butyrate, acetate and propionate levels.
Result: NRP-1 expression was inversely related to SCFA concentration at the colon landmark (mid-sigmoid), but
expression was lower and not related to SCFA concentration at the field. Likewise CgA+ cell number was also
inversely related to SCFA at the landmark, but was lower and unresponsive at the field. Crypt cellularity was
unaltered by field effect. A colocalisation analysis showed only a small subset of NRP-1 localised with CgA.
Adenomas showed extensive, weaker staining for NRP-1 which contrastingly correlated positively with butyrate
level. Field effects cause this relationship to be lost. Adenoma tissue shows dissociation of the co-regulation of
NRP-1 and EEC.
Conclusion: NRP-1 is inversely associated with levels of butyrate and other SCFA in vivo and is expressed in a
subset of CgA expressing cells. EEC number is related to butyrate level in the same way.
Background
The incidence of colorectal cancer has been shown to be
decreased in populations with a high dietary fibre intake
[1,2]. This effect is thought be attributable in part to the
cellular actions of butyrate, a short-chain fatty acid
(SCFA) produced by fermentation of fibre and resistant
starch in the human colon lumen [3]. Butyrate is
thought to be a chemoprotective effector, inhibiting
colon carcinogenesis through regulation of cell cycle,
apoptosis and angiogenic pathways [1,4-6].
Our recent data show that the transmembrane glyco-
protein neuropilin-1 (NRP-1) is downregulated by buty-
rate in several colon cancer cell lines [7]. NRP-1 was
originally characterised as a neuronal semaphorin recep-
tor [8,9] and has since been identified as a non-tyrosine
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kinase co-receptor for some isoforms of the vascular
endothelial growth factor (VEGF) family, the most
potent pro-angiogenic family identified to date [10].
Angiogenesis is essential for tumour development and is
stimulated at the earliest stages of the adenoma-
carcinoma sequence in the colon and correlates with an
increase in VEGF expression [11]. NRP-1 is up-regulated
not only in vessels within adenomas and carcinomas,
but also in hyperplastic adenoma cells and invasive
colon cancer compared to normal mucosa. Overexpres-
sion of NRP-1 in these contexts is thought to enhance
cancer cell survival [12] leading to cancer progression,
metastatic potential and potential chemoresistance [13].
Immunohistochemical analysis has also identified NRP-1
expression in a subset of singly dispersed colonic epithe-
lial cells [13,14] interpreted as enteroendocrine cells
(EEC). However, regulation of this expression in normal
mucosa remains uncharacterised.
Enteroendocrine cells (EEC) are hormone-producing
intestinal epithelial cells that are individually dispersed
throughout the epithelium where they have a critical
role in regulating gastrointestinal physiology [15]. The
numbers of colonic EEC have been shown to alter in
conditions including irritable bowel syndrome [16] and
cancer [17,18]. Indeed, the numbers of chromagranin A
(CgA)-expressing EEC was shown to be decreased in
mucosa adjacent to colon tumours compared to normal
mucosa [18], although the mechanisms regulating this
change are currently unknown. EEC have been shown
to express the G-protein coupled receptors, GPR41 and
GPR43, for SCFA including butyrate, acetate and pro-
pionate [19], suggesting that these cells may mediate, at
least in part, the colon epithelial response to SCFA.
Our recent data show an inverse causal relationship
between butyrate concentration and NRP-1 expression
at both the mRNA and protein level in vitro [7]. We
hypothesize that this is a representative model of in vivo
systems and the same relationship will occur in vivo. In
the present study we have investigated the relationship
between faecal butyrate, acetate and propionate concen-
tration and NRP-1 expression in human colonic mucosa.
Furthermore, as NRP-1 expression is limited in the nor-
mal mucosa and is widespread in cancer tissue, we
sought to investigate the expression profile of NRP-1 in
adenoma and in fields around adenoma to map the
onset of NRP-1 dysregulation. We have undertaken the
same analyses on EEC and sought to establish whether
EEC are the NRP-1 expressing compartment of the
colon mucosa.
Results
Subject demographics
A total of 28 subjects with adenoma were recruited for
whom biopsies and faecal butyrate data were available.
All subjects were included. Subjects had a mean age of
68.1 ± 10.1 yr and a mean BMI of 25.5 ± 3.4 kg/m2.
The concentration range of faecal butyrate was 0.64-
16.4 mM.
Butyrate level does not correlate with human colon crypt
cellularity
In order to investigate any baseline associations between
butyrate concentration and field effect on crypt cell
number and to contextualize the main assessment of the
impacts of these two factors on the proportion of NRP-1
and CgA positive cells, the total number of cells per
hemi-crypt across 10 hemi-crypts per sample was deter-
mined on samples from 23 field and 28 mid-sigmoid
specimens. The correlation between crypt cellularity and
butyrate level was assessed by Spearman’s rho (Figure
1A) and using Jonkheere-Terpstra (Figure 1B). These
analyses show that there were no significant differences
in crypt cellularity associated with butyrate level or asso-
ciated with the adenoma field (Figure 1).
Butyrate is associated with reduced NRP-1 protein
expression in normal colon epithelial cells
It has previously been reported that NRP-1 is expressed
in singly dispersed cells within the colorectal epithelium
[13,14] and is down-regulated by butyrate in vitro [7].
To investigate whether NRP-1 expression is associated
with butyrate or other SCFA concentration in human
non-malignant colonic epithelium, IHC staining was
performed on 23 samples from the contralateral walls to
the adenoma (fields) and 26 samples from mid-sigmoid
of the same subjects (a constant landmark sampling
point in all subjects). Only a small number of cells
expressed NRP-1 in either the field (0.34% of crypt
cells) or the mid-sigmoid (0.94% of crypt cells) speci-
mens. There is a strongly negative correlation between
butyrate concentration and NRP-1 positive cell count in
mid-sigmoid (r = -0.622, p < 0.001; Figure 2 Table 1),
however, this relationship was lost in the field (r =
-0.258, p = 0.235; Figure 2 Table 1), where all crypts
exhibit low numbers of NRP-1 positive cells (Figure 2A).
Similarly when the data were grouped into tertiles by
butyrate concentration: high (> 8 mM), medium
(2-8 mM) and low (< 2 mM), there was a significant dif-
ference between groups at the mid-sigmoid landmark
site (Jonkheere-Terpstra, p = 0.013). A post hoc analysis
revealed that the NRP-1 positive cell count in the low
butyrate group (1.69%) was significantly higher than in
medium (0.62%, p = 0.016) and high (0.47%, p = 0.009)
butyrate groups (Figure 2B). Interestingly, under condi-
tions of low butyrate the percentage of NRP-1 expres-
sing cells is significantly lower in the adenoma field
compared to the landmark samples (p = 0.003, Figure 2C).
Taken together, these data show that butyrate (> 8 mM) is
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Figure 1 Relationship between butyrate concentration and crypt cellularity. The total number of cells per hemi-crypt was counted on 23
samples in contra lateral (field) and 28 samples in mid-sigmoid. (A) Graphs demonstrating that there was no relationship between cell number
and butyrate at the field and mid-sigmoid. (B) The data were grouped into tertiles by butyrate concentration at high (> 8 mM), medium (2-8
mM) and low (< 2 mM) and presented as the mean ± SEM. The mean total cell number was 46.40/hemi-crypt in field tissue and 44.17/hemi-
crypt in mid-sigmoid respectively showing no difference in crypt cellularity between field and mid-sigmoid samples.
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Figure 2 NRP-1 protein expression in human colon epithelial cells. The percentage of NRP-1 positive staining cells was calculated in crypts
in the field and mid-sigmoid samples. (A) Graphs showing no relationship between butyrate concentration and NRP-1 expression in the field
(contra-lateral) but a strong inverse correlation at the mid-sigmoid (r = -0.622; p = 0.001) (B) Graph showing the data as mean ± SEM when
grouped into tertiles according to butyrate concentration. In the contra-lateral samples there were no differences seen, but in the mid-sigmoid a
significant difference was seen between the low butyrate and mid/high butyrate groups (p < 0.015). (C) Graph comparing butyrate
concentration and the percentage of NRP-1 expression in the contralateral (white bars) and mid-sigmoid (filled bars) samples. NRP-1 expression
was significantly higher in the low butyrate group in the mid-sigmoid compared to the field (p = 0.003), but no other differences between
sample sites were seen.
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associated with a reduction in the number of NRP-1
expressing cells in normal colorectal mucosa. Similar
results were seen with acetate and propionate (see
Table 1). This relationship is lost in the vicinity of
adenoma, suggesting a field change in which normal regu-
latory mechanisms are suppressed.
Butyrate is associated with reduced CgA expressing cell
number in the colon epithelium
The distribution of NRP-1 positive cells in normal colon
epithelium mirrors that of enteroendocrine cells (EEC)
[15]. The cell morphology of NRP-1 staining cells was
also similar to that of EECs: relatively small nuclei and
basally oriented cytoplasm, often without obvious conti-
nuity with the lumen. Moreover, EEC are known to
express SCFA receptors [19]. Therefore in order to
establish whether EEC number itself is associated with
butyrate, acetate or propionate concentration in human
normal colon tissue, IHC staining for CgA, a tissue
marker for the majority of EEC subtypes [20], was
undertaken on 23 samples in field and 28 samples in
mid-sigmoid. CgA expression was observed in a small
number of singly dispersed epithelial cells within
the normal colon, up to 1.4% cells within a crypt (See
Figure 6A). Spearman’s rho analysis revealed a near-
significant inverse correlation between the percentage of
CgA expressing cells/crypt and butyrate concentration
in the mid-sigmoid (landmark) samples (r = -0.370, p =
0.053; Figure 3 Table 1), but not in field samples (r = 0;
p = 1.000; Figure 3 Table 1). When data were split into
tertiles by butyrate level, the CgA positive cell fraction
at low butyrate (1.82%) was higher than the medium
(1.21%) and significantly higher than the high butyrate
(1.11%) groups (p = 0.037) in mid-sigmoid sections
(Figure 3B). There were no significant differences in the
number of cells expressing CgA between field and
mid-sigmoid samples or within fields, when grouped by
butyrate level (Figure 3C). These data show that, as
with NRP-1 expression, faecal butyrate concentration is
associated with changes in endocrine cell numbers in
normal human colon tissue, but that this relationship is
flattened by field effects around adenoma. Relationships
between EEC and acetate and propionate did not reach
significance, although the direction of response to SCFA
and field was as for butyrate (Table 1).
NRP-1 expression only partly co-localizes with
chromagranin A
In order to establish whether NRP-1 is expressed in the
EEC compartment, adjacent sections stained for NRP-1
and CgA respectively were assessed for co-localisation
(see Figure 4A). In both the field and landmark sites
fewer than 10% of the CgA positive cells expressed
NRP-1+ and fewer than 20% of the NRP-1 positive
cells expressed CgA+ (Figure 5A). The levels of co-
localisation did not alter between field and landmark
sites (Figure 5A). Weak inverse correlations were seen
between the number of NRP-1+/CgA+ and NRP1-/CgA
+ cells at the mid-sigmoid site and butyrate levels and
a significant inverse correlation was seen in the NRP-1
+/CgA- cells (r = -0.473; p = 0.017; Figure 4B). In con-
trast there were no significant correlations seen
between butyrate and NRP-1+/CgA+, NRP-1+/CgA-
and NRP-1-/CgA+ cells at the field site. Taken together
these data show that NRP-1 expression does not predo-
minantly co-localise with CgA expression.
Butyrate is associated with increased NRP-1 protein
expression in human polyp adenomas
Previous studies have suggested that NRP-1 expression
correlates with tumour growth and invasiveness in col-
orectal cancer [12] and that there is an increase in both
intensity and area of expression from low-grade to high-
grade dysplasia in colorectal adenomas [13]. Therefore
in order to determine and confirm the expression pat-
tern of NRP-1 in colon adenomas and to establish
whether it is associated with butyrate concentration,
IHC staining was performed on 16 human polyp sam-
ples from the same subjects. NRP-1 expression was gen-
erally expressed widely within the adenomas, albeit at a
lower staining intensity than in cells in the normal
mucosa (Compare Figure 4A and B with Figure 4C).
NRP-1 staining was assessed, considering both staining
intensity and the percentage of positively staining cells,
using semi-quantitative scales. A strong positive
Table 1 Correlations between SCFA and Np1 or CgA on
adenoma specimens from Mid-sigmoid (MS) or contra-
lateral wall (CL)
SCFA Site marker Spearman’s rho p-value
Butyrate MS Np1 % -0.622 0.001**
Butyrate CL Np1 % -0.258 0.235
Butyrate MS CgA % -0.370 0.053*
Butyrate CL CgA % 0 1.000
Acetate MS Np1 % -0.653 0.001**
Acetate CL Np1 % -0.214 0.328
Acetate MS CgA % -0.224 0.251
Acetate CL CgA % 0.033 0.883
Propionate MS Np1 % -0.555 0.003**
Propionate CL Np1 % -0.144 0.511
Propionate MS CgA % -0.130 0.511
Propionate CL CgA % 0.032 0.886
Isobutyrate MS Np1 % -0.309 0.125
Isobutyrate CL Np1 % -0.232 0.287
Isobutyrate MS CgA % -0.224 0.251
Isobutyrate CL CgA % -0.213 0.328
**highly significant; *approaching significance.
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Figure 3 CgA protein expression in human colon epithelial cells. The percentage of CgA positive staining cells was calculated in crypts in
the field and mid-sigmoid samples. (A) Graphs showing no relationship between butyrate concentration and CgA expression in the field (contra-
lateral) but a moderate, almost significant inverse correlation at the mid-sigmoid (r = -0.370; p = 0.053) (B) Graph showing the data as mean ±
SEM when grouped into tertiles according to butyrate concentration. In the contra-lateral samples there were no differences seen, but in the
mid-sigmoid a significant difference was seen between the low butyrate and high butyrate groups (p = 0.037). (C) Graph comparing butyrate
concentration and the percentage of CgA expression in the contralateral (white bars) and mid-sigmoid (filled bars) samples. No significant
differences were seen between the field and mid-sigmoid samples in any groups.
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correlation was seen between staining intensity and
butyrate (r = 0.517; p = 0.040) and a near-significant
correlation was seen between the percentage of positive
cells and butyrate (r = 0.467; p = 0.053; Figure 6). When
the data were grouped into tertiles by butyrate concen-
tration there was a significant difference seen between
the high and low butyrate groups (p = 0.026; Figure 6).
Taken together these data suggest that NRP-1 expres-
sion is altered in adenomas and may be up-regulated by
butyrate. Adjacent adenoma sections were concomi-
tantly stained with CgA. In contrast with the NRP-1
staining pattern which altered markedly in adenoma by
comparison with normal tissue, the CgA staining
remained limited to singly dispersed cells (Figure 4D).
i 20x ii 20x iii 20x iv 20x
iv 20X
i 20X ii 20X iii 20X
v 20X vi 20X
i 20x ii 20x
A
C
D
B
Figure 4 Representative images of NRP-1 and CgA staining. (A) Serial sections of mid-sigmoid samples and (B) contra-lateral (field) samples
stained for NRP-1 (left) and CgA (right). Red arrow heads identify cells staining for NRP-1 only, black arrow heads identify cells staining for both
NRP-1 and CgA and yellow arrow heads identify cells staining for CgA only. (C) Samples of adenoma demonstrating different intensities of
staining and different percentage of cells staining for NRP-1 (D) Samples of adenoma showing only one or two cells staining for CgA.
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Cell type NRP1+/CgA+ NRP1+/CgA- NRP1-/CgA+
Mid-sigmoid
r(p)
-0.070 (0.741) -0.473(0.017) -0.297(0.149)
Contra lateral
r(p)
0.363(0.089) -0.190(0.384) 0.361(0.141)
A
B
C
Figure 5 Co-localisation of NRP-1 and CgA expression in human colon epithelial cells. The co-localisation of NRP-1 and CgA expression
was calculated in up to 400 cells in crypts in the field and mid-sigmoid samples. (A) Graphs showing of the relative abundance of NRP-1+/CgA-,
NRP-1+/CgA+ and NRP-1-/CgA+ cells both in the field and mid-sigmoid and the data presented as the mean ± SEM (B) Graphs showing the
relationships between NRP-1 and CgA colocalising and non-colocalising cells relative to butyrate level in the field and mid-sigmoid landmark.
A significantly negative correlation was seen in the NRP1+/CgA- cells in landmark (r = -0.473, p = 0.017). (C) The correlation was carried out by
Spearman’s statistics and the data were shown in r(p) value when grouped into NRP-1+/CgA+, NRP-1+/CgA- and NRP-1-/CgA+ in the field and
landmark respectively.
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Discussion
Previous studies have suggested that NRP-1 expression
correlates with tumour growth and invasiveness in color-
ectal cancer [12] and that there is an increase in both
intensity and area of expression from low-grade to high-
grade dysplasia in colorectal adenomas [13]. The same
studies have also reported that in the morphologically
normal colon epithelium NRP-1 is expressed in a singly
dispersed subpopulation of cells - with a distribution and
frequency which we hypothesised might reflect localisa-
tion to EEC. Our recent data [7] show that butyrate, a
product of fibre fermentation in the colon lumen, down-
regulates NRP-1 expression in colon cancer cell lines and
we hypothesized that butyrate, and potentially other
NRP1
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Figure 6 NRP-1 protein expression in human polyps. The expression of NRP-1 in human colorectal adenoma was characterised as intensity
of stain (0-2; 0: no expression, 1: moderate expression and 2: strong expression) or the percentage of the adenoma cells expressing NRP-1. The
data is presented as mean ± SEM and split into tertiles according to butyrate concentration. The graphs demonstrate lower NRP-1 expression
correlates with lower butyrate level and a significant difference is seen between groups (Jonckeere-Terpstra; p = 0.026). Post-hoc analysis (Mann-
Whitney U test) identified significance between the low and high butyrate groups with NRP-1 expression intensity, but not with the percentage
of expressing NRP-1.
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SCFA, produced in the lumen would have an analogous
effect on the colon mucosa in vivo. We therefore sought
to establish whether such a relationship exists in vivo.
Our studies confirm that NRP-1 is expressed in a sub-
population of individual dispersed cells within the colo-
nic crypt epithelium, in agreement with previous data
[13], and we observed that both the morphology and
distribution of the NRP-1 cells resembled that of EECs.
The expression of NRP-1 was inversely associated with
faecal butyrate concentrations in agreement with our
in vitro findings. Similar results were seen with acetate
and propionate. These data suggest that the NRP-1
expressing cells are SCFA-responsive. Previous studies
have identified SCFA receptors GPR41 and GPR43 on
singly dispersed cells within the colonic mucosa [19]
thought to be EEC. GPR41 was only expressed on 0.01
± 0.01 cells/crypt and the staining was more frequent at
the surface epithelium than the bottom of the crypt,
unlike the staining seen for NRP-1. In contrast GPR43
was expressed in 0.33 ± 0.01 cells/crypt and was more
evenly dispersed throughout the crypt i.e. similar to our
staining for NRP-1 (an average of 0.37 ± 0.03 cells/
crypt). GPR43 staining is specific to L-cells [21], which
produce glucagon-like peptide-1 (GLP-1) and peptide
YY (PYY) [22].
Although CgA is at present considered to be the broad-
est EEC marker, some EEC sub-populations are CgA
negative [20]. The anti-CgA antibody used in this study
has been reported as non-reactive in L-cells. As only a
minority of CgA+ EECs express NRP-1 and the majority
of NRP-1 expression is out with the CgA+ compartment,
we hypothesize that NRP-1 is predominantly expressed
in a different subset of EEC such as L-cells. It is notable
that luminal non-digestible carbohydrates have been
shown to modulate L-cell numbers in the rat [23]. As
with the expression of NRP-1, there is an inverse rela-
tionship in the mid-sigmoid colon between CgA+ cells
and SCFA, albeit only significantly with butyrate. The
relationship was lost in the field adjacent to adenoma in
the same subjects. A previous study in xenograft mice
has shown that the presence of a tumour (even distant to
the intestine) depresses EEC cell number in the intestine
[24], suggesting that a tumour expresses a diffusible fac-
tor which alters the normal regulatory mechanism for
EEC number. Our data support this finding and show for
the first time that EEC number is altered in the vicinity
of a tumour in humans.
NRP-1 has been linked to cancer progression and
aggressiveness in colon tumours [13]. Our data examin-
ing the expression pattern of NRP-1 and CgA in adeno-
mas show that, whereas there are similarities and
overlaps in morphologically normal tissue, the regula-
tion of the two markers becomes profoundly unlinked
in adenomas. The expression of CgA remains in singly
dispersed cells (Figure 6D), as previously reported [18]
and owing to the disorganised nature of the tissue and
infrequent positive cells, scoring of the numbers of posi-
tives was not possible. In contrast NRP-1 expression
was profoundly different to that seen in normal tissue.
The staining in individual cells was generally lower in
intensity, however it was no longer restricted to indivi-
dual dispersed cells, but in many of the sections large
areas stained positively, as seen in previous studies [13].
The pattern was scored for both intensity and propor-
tion of positive staining and, in stark contrast to obser-
vations at the morphologically normal sites, showed a
strong positive relationship with butyrate level. NRP-1
has been implicated as an anti-apoptotic protein in
colon cancers [14] in addition to its role in angiogenesis
[12], which is reinforced by its staining pattern not
being limited to obvious microvessels. The staining pat-
tern implicates NRP-1 as dysregulated early in adenoma-
genesis and it is likely that the role is, at least in part,
anti-apoptotic in order to facilitate the growth and pro-
pagation of deranged tissue.
A plethora of in vitro studies using butyrate treatment
of cell lines has shown that it induces apoptosis and cell
cycle arrest at physiologically achievable concentrations
(circa 1-10mM). Given that loss of regulation of both cell
cycle and resistance to apoptosis are hallmarks of the
cancer cell [25], these effects have been proposed as the
key effectors of butyrate’s hypothesized anti-neoplastic
effect. However, these findings alone cannot explain the
specificity of the effect and are offset by obverse findings
regarding the cell cycle-promoting effects of butyrate on
the normal colonocyte [26], leading to proposal of the
“butyrate paradox” [27]. The implication of the butyrate
paradox is that there may be a key change in early carci-
nogenesis which sensitizes the mutant colonocyte to nor-
mal levels of butyrate. However, Lupton [28,29] and our
group [30] have asserted that some of the paradox can be
explained by differences in experimental protocols and
cellular and animal models used in different laboratories.
The results herein suggest for the first time that opposing
responses to butyrate can be seen in the normal and dys-
plastic colon. This implies a veracity in the paradox
hypothesis in terms of altered response. However these
data contradict the paradox hypothesis insofar as faecal
butyrate levels associate with a factor, NRP-1, promoting
poor prognosis rather than acting as a selective anti-neo-
plastic agent. As with folate, which protects against ade-
noma formation but which supports the growth of
developed adenomas [31,32], butyrate (or more specifi-
cally the faecal stream) has been implicated in the contin-
ued growth of colorectal adenomas once formed [33].
These data support profound alterations in regulatory
networks underpinning the earliest stages of adenoma
formation and, as with folate, suggest caution is
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warranted in giving the same dietary advice for primary
as for secondary chemoprevention.
One limitation of this study is the use of faecal SCFA
as a proxy measure of luminal SCFA. There is a grada-
tion of level of SCFA within the different regions of the
colon lumen [34] but sampling luminal contents in
humans remains a significant challenge to researchers in
this field. Furthermore the SCFA level in itself may only
represent a proxy measure of a further luminal metabo-
lite with potentially stronger and causal effects on NRP-
1 expression. As technologies for faecal metabonomics
emerge, such possibilities may be explored in future.
Taken together our data provide evidence for progres-
sive field effects in the vicinity of colon adenoma and in
adenoma. Both NRP-1 and EEC number decreased in
relation to increasing SCFA concentrations at sites dis-
tant to the adenoma. In the immediate field (our biopsy
protocol sampled at the contra lateral wall) this apparent
relationship to SCFA level is lost and in the neoplasia the
effect is reversed with neuropilin showing positive asso-
ciation with butyrate and dissociated from EEC-like
expression. Our data therefore suggest a progressive and
complete reversal of the response to butyrate as a hall-
mark of field effects. Despite widespread acceptance of
the field effect hypothesis [35-37] in colon carcinogen-
esis, we are aware of only one publication showing
demonstrable molecular alterations at fields [38] high-
lighting the need to pursue this area of study more.
Conclusion
In summary our data show that NRP-1 is expressed in the
normal colon epithelium in a pattern redolent of EEC, and
this expression appears related to butyrate levels, in agree-
ment with the hypothesis raised from our in vitro data.
NRP-1 expression is related to SCFA expression, but this
association is lost in fields and expression becomes
unlinked from EEC-like patterns in adenomatous tissue,
implying an early and potential alternative role for NRP-1
in neoplasia. Our data showed for the first time that EEC
number is also related to butyrate concentration. Future
studies will now address whether there is a difference in
EEC number in normal subjects by comparison with those
carrying an adenoma, to examine whether there are pan-
colon field effects in addition to local effects. Studies must
also establish what the role and interactions of NRP-1 are
in the normal colon epithelium in order to establish a
clear role for butyrate in the regulation of function as well
as homeostasis.
Materials and methods
Patient samples and data collection
The study protocol through which samples were
acquired has been described elsewhere in detail [39].
Briefly, male patients attending gastroenterology clinics
and scheduled for routine endoscopy were recruited to
the study. All patients in this study were diagnosed with
colorectal adenomas and patients with synchronous
pathologies were excluded. Biopsies were collected from
the mid-sigmoid (as a conserved landmark between all
subjects), from the adenoma and from the contralateral
wall to the adenoma (to monitor field effects) during
endoscopy. Biopsies were formalin fixed, paraffin
embedded (FFPE) and sectioned at multiple levels.
A gastrointestinal histopathologist examined all sample,
confirming the absence of co-incident pathology in the
normal mucosa, and that all adenomas exhibit low-
grade dysplasia only. Patients also provided a stool sam-
ple, which was extracted for SCFA analysis [39]. The
stool sample was collected whilst patients experienced
normal bowel habit and not during or immediately after
laxative preparation for clinic. The study was approved
by North Sheffield Research Ethics Committee (REF: 06/
Q2308/93).
Immunohistochemistry (IHC) for NRP-1 and CgA
NRP-1 and CgA were stained in serial sections to enable
analysis of co-localisation of the two factors. Antigen
retrieval was performed using heat induced epitope
retrieval using a microwave oven, with citrate buffer
(pH6) for NRP-1 and DAKO Target Retrieval Solution
(DAKO) for CgA. For NRP-1 staining a polyclonal rab-
bit anti-human NRP-1 antibody (Santa Cruz) and for
CgA staining a monoclonal mouse anti-CgA antibody
(DAKO) were used. A standard horse-radish peroxidise
staining procedure was performed for both antibodies,
using biotinylated antibodies (Vector Laboratories,
Peterborough) followed by the elite ABC kit (Avidin:Bio-
tinylated enzyme complex; Vector laboratories) and
DAB as the chromogen substrate (Vector laboratories)
for visualisation. Sections of normal mucosa from the
landmark site and adenoma field (contralateral wall)
were scored as the percentage of positively stained cells
per hemi-crypt for each marker. Only well-orientated
hemi-crypts were scored, up to a maximum of 10/sec-
tion. To assess the colocalisation of NRP-1 and CGA,
staining was performed in serial sections and 400 cells
classified as GCA+ /NRP+, CGA+ /NRP-, GCA- /NRP+,
and CGA- /NRP-,. Adenomas were scored for the inten-
sity and percentage of positive NRP-1 and positive or
negative of CgA stained cells per each section. All stain-
ing was scored by an assessor (DY) blinded to the cases
and trained by the project histopathologist (JPB), and
second scored by the project histopathologist. The co-
localisation analysis was double scored by two assessors
(DY & JT), under the supervision of the project
pathologist.
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Statistical Analysis
Statistical analysis into the relationship between NRP-1
or CgA staining and faecal butyrate was conducted
using SPSS v18 software (Chicago, IL, USA). As the
continuous data were not normally distributed the cor-
relation between faecal butyrate levels and NRP-1 or
CgA expression was analysed using Spearman’s correla-
tion statistics. A further analysis grouped the samples
into tertiles by faecal butyrate and used the nonpara-
metric Jonckheere-Terpstra test for ordinal categorical
groupings. Data were considered statistically significant
at the level of p < 0.05.
Acknowledgements
This work was funded by Yorkshire Cancer Research and the Food Standards
Agency (N12017).
Authors’ contributions
DCWY undertook all laboratory work, preliminary statistical analysis and
wrote the first draft of the paper; JPB directed the development of IHC
methods and directed statistical analysis, co-wrote and edited the
manuscript; JT undertook the colocalisation analysis; JSW supervised
laboratory work and co-conceived the study; CAS co-conceived the study,
undertook statistical analyses, co-wrote and edited the manuscript; BMC
conceived the study, directed the work and co-wrote and edited the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 10 June 2010 Accepted: 14 March 2011
Published: 14 March 2011
References
1. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-
Chapelon F, Kesse E, Nieters A, Boeing H, et al: Dietary fibre in food and
protection against colorectal cancer in the European Prospective
Investigation into Cancer and Nutrition (EPIC): an observational study.
Lancet 2003, 361:1496-1501.
2. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R,
Weissfeld JL, Flood A, Schatzkin A, Hayes RB: Dietary fibre and colorectal
adenoma in a colorectal cancer early detection programme. Lancet 2003,
361:1491-1495.
3. McIntyre A, Gibson PR, Young GP: Butyrate production from dietary fibre
and protection against large bowel cancer in a rat model. Gut 1993,
34:386-391.
4. Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA: Combination of
phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth
and angiogenesis. Cancer Res 2001, 61:1477-1485.
5. Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD:
Induction of caspase-3 protease activity and apoptosis by butyrate and
trichostatin A (inhibitors of histone deacetylase): dependence on protein
synthesis and synergy with a mitochondrial/cytochrome c-dependent
pathway. Cancer Res 1997, 57:3697-3707.
6. Schwartz B, Avivi-Green C, Polak-Charcon S: Sodium butyrate induces
retinoblastoma protein dephosphorylation, p16 expression and growth
arrest of colon cancer cells. Mol Cell Biochem 1998, 188:21-30.
7. Yu DC, Waby JS, Chirakkal H, Staton CA, Corfe BM: Butyrate suppresses
expression of neuropilin I in colorectal cell lines through inhibition of
Sp1 transactivation. Mol Cancer 2010, 9:276.
8. He Z, Tessier-Lavigne M: Neuropilin is a receptor for the axonal
chemorepellent Semaphorin III. Cell 1997, 90:739-751.
9. Kowanetz M, Ferrara N: Vascular endothelial growth factor signaling
pathways: therapeutic perspective. Clin Cancer Res 2006, 12:5018-5022.
10. Staton CA, Kumar I, Reed MW, Brown NJ: Neuropilins in physiological and
pathological angiogenesis. J Pathol 2007, 212:237-248.
11. Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MW: The
angiogenic switch occurs at the adenoma stage of the adenoma
carcinoma sequence in colorectal cancer. Gut 2007, 56:1426-1432.
12. Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N,
Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM: Neuropilin-1 in human
colon cancer: expression, regulation, and role in induction of
angiogenesis. Am J Pathol 2004, 164:2139-2151.
13. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A:
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and
metastases of the human gastrointestinal tract. Am J Surg Pathol 2004,
28:347-356.
14. Ochiumi T, Kitadai Y, Tanaka S, Akagi M, Yoshihara M, Chayama K:
Neuropilin-1 is involved in regulation of apoptosis and migration of
human colon cancer. Int J Oncol 2006, 29:105-116.
15. Aiken KD, Kisslinger JA, Roth KA: Immunohistochemical studies indicate
multiple enteroendocrine cell differentiation pathways in the mouse
proximal small intestine. Dev Dyn 1994, 201:63-70.
16. Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of
enterochromaffin cell hyperplasia, anxiety, and depression in
postinfectious IBS. Gastroenterology 2003, 125:1651-1659.
17. Nitta Y, Nishibori M, Iwagaki H, Yoshino T, Mori S, Sawada K, Nakaya N,
Saeki K, Tanaka N: Changes in serotonin dynamics in the gastrointestinal
tract of colon-26 tumour-bearing mice: effects of cisplatin treatment.
Naunyn Schmiedebergs Arch Pharmacol 2001, 364:329-334.
18. Gulubova M, Vlaykova T: Chromogranin A-, serotonin-, synaptophysin-
and vascular endothelial growth factor-positive endocrine cells and the
prognosis of colorectal cancer: an immunohistochemical and
ultrastructural study. J Gastroenterol Hepatol 2008, 23:1574-1585.
19. Tazoe H, Otomo Y, Karaki S, Kato I, Fukami Y, Terasaki M, Kuwahara A:
Expression of short-chain fatty acid receptor GPR41 in the human colon.
Biomed Res 2009, 30:149-156.
20. Portela-Gomes GM, Stridsberg M, Johansson H, Grimelius L: Complex
co-localization of chromogranins and neurohormones in the human
gastrointestinal tract. J Histochem Cytochem 1997, 45:815-822.
21. Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y,
Kuwahara A: Expression of the short-chain fatty acid receptor, GPR43, in
the human colon. J Mol Histol 2008, 39:135-142.
22. Kim BJ, Park KH, Yim CY, Takasawa S, Okamoto H, Im MJ, Kim UH:
Generation of nicotinic acid adenine dinucleotide phosphate and cyclic
ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is
essential for insulin secretion in mouse pancreatic islets. Diabetes 2008,
57:868-878.
23. Cani PD, Hoste S, Guiot Y, Delzenne NM: Dietary non-digestible
carbohydrates promote L-cell differentiation in the proximal colon of
rats. Br J Nutr 2007, 98:32-37.
24. Cho KH, Lee HS, Ku SK: Decrease in intestinal endocrine cells in Balb/c
mice with CT-26 carcinoma cells. J Vet Sci 2008, 9:9-14.
25. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000,
100:57-70.
26. Roediger WE: Utilization of nutrients by isolated epithelial cells of the rat
colon. Gastroenterology 1982, 83:424-429.
27. Velazquez OC, Lederer HM, Rombeau JL: Butyrate and the colonocyte.
Implications for neoplasia. Dig Dis Sci 1996, 41:727-739.
28. Lupton JR: Microbial degradation products influence colon cancer risk:
the butyrate controversy. J Nutr 2004, 134:479-482.
29. Lupton JR: Is fiber protective against colon cancer? Where the research
is leading us. Nutrition 2000, 16:558-561.
30. Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM:
Upregulation of BAK by butyrate in the colon is associated with
increased Sp3 binding. Oncogene 2006, 25:7192-7200.
31. Kim YI: Will mandatory folic acid fortification prevent or promote cancer?
Am J Clin Nutr 2004, 80:1123-1128.
32. Giovannucci E: Epidemiologic studies of folate and colorectal neoplasia: a
review. J Nutr 2002, 132:2350S-2355S.
33. Cole JW, Holden WD: Postcolectomy regression of adenomatous polyps
of the rectum. Arch Surg 1959, 79:385-392.
34. Macfarlane S, Macfarlane GT: Regulation of short-chain fatty acid
production. Proc Nutr Soc 2003, 62:67-72.
35. Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral
stratified squamous epithelium; clinical implications of multicentric
origin. Cancer 1953, 6:963-968.
Yu et al. Molecular Cancer 2011, 10:27
http://www.molecular-cancer.com/content/10/1/27
Page 12 of 13
36. Humphries A, Wright NA: Colonic crypt organization and tumorigenesis.
Nat Rev Cancer 2008, 8:415-424.
37. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic
explanation of Slaughter’s concept of field cancerization: evidence and
clinical implications. Cancer Res 2003, 63:1727-1730.
38. Polley AC, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ,
Mathers JC, Johnson IT: Proteomic analysis reveals field-wide changes in
protein expression in the morphologically normal mucosa of patients
with colorectal neoplasia. Cancer Res 2006, 66:6553-6562.
39. Corfe BM, Williams EA, Bury JP, Riley SA, Croucher LJ, Lai DY, Evans CA: A
study protocol to investigate the relationship between dietary fibre
intake and fermentation, colon cell turnover, global protein acetylation
and early carcinogenesis: the FACT study. BMC Cancer 2009, 9:332.
doi:10.1186/1476-4598-10-27
Cite this article as: Yu et al.: Short-chain fatty acid level and field
cancerization show opposing associations with enteroendocrine cell
number and neuropilin expression in patients with colorectal adenoma.
Molecular Cancer 2011 10:27.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yu et al. Molecular Cancer 2011, 10:27
http://www.molecular-cancer.com/content/10/1/27
Page 13 of 13
